Abstract
Prenatal diagnosis is important part of obstetric practice (Tounta et al. 2011). Traditionally, fetal DNA is obtained by invasive techniques, namely, amniocentesis and chorionic villus sampling. Such invasive procedure leads to a miscarriage rate of about 1 % and is reserved only for high risk pregnancies for specific genetic conditions which include fetal chromosomal aneuploidies and monogenic disorders with relatively high prevalence in the relevant populations. The ultimate goal for early prenatal diagnosis, while decreasing the miscarriage rate, is to employ noninvasive testing using maternal peripheral blood as a source of fetal genetic material (Tounta et al. 2011). Multiple studies indicate that both intact fetal cells and cell-free fetal nucleic acids (cffNA) cross the placenta and can be found in the maternal circulation. Intact fetal cells present an attractive target for noninvasive prenatal diagnosis (NIPD) of fetal chromosomal abnormalities (Lo et al. 1996). Isolation and analysis of fetal cells from maternal circulation have been extensively investigated and several methods for fetal cell enrichment have been developed (Bianchi 1999; Jackson 2003; Sekizawa et al. 2007). However, due to the lack of cells in the maternal circulation and low efficiency of enrichment methods results have not been promising. In addition, it has been challenging to perform Fluorescent In Situ Hybridization (FISH) because of the presence of apoptotic nuclei of fetal cells (Bianchi et al. 1997).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Avent ND, Chitty LS (2006) Non-invasive diagnosis of fetal sex; utilisation of free fetal DNA in maternal plasma and ultrasound. Prenat Diagn 26:598–603. doi:10.1002/pd.1493
Avent ND, Madgett TE, Maddocks DG, Soothill PW (2009) Cell-free fetal DNA in the maternal serum and plasma: current and evolving applications. Curr Opin Obstet Gynecol 21:175–179. doi:10.1097/GCO.0b013e3283294798
Bianchi DW (1999) Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br J Haematol 105:574–583
Bianchi DW, Williams JM, Sullivan LM et al (1997) PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61:822–829. doi:10.1086/514885
Bianchi DW, Avent ND, Costa J-M, van der Schoot CE (2005) Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 106:841–844. doi:10.1097/01.AOG.0000179477.59385.93
Bustamante-Aragones A, Gallego-Merlo J, Trujillo-Tiebas MJ et al (2008) New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma. J Cyst Fibros 7:505–510. doi:10.1016/j.jcf.2008.05.006
Canick JA, Palomaki GE, Kloza EM et al (2013) The impact of maternal plasma DNA fetal fraction on next-generation sequencing tests for common fetal aneuploidies. Prenat Diagn 33(7):667–674. doi:10.1002/pd.4126
Chan KCA, Zhang J, Hui ABY et al (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50:88–92. doi:10.1373/clinchem.2003.024893
Chen EZ, Chiu RWK, Sun H et al (2011) Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 6:e21791. doi:10.1371/journal.pone.0021791
Chiu RWK, Lau TK, Cheung PT et al (2002a) Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study. Clin Chem 48:778–780
Chiu RWK, Lau TK, Leung TN et al (2002b) Prenatal exclusion of beta thalassaemia major by examination of maternal plasma. Lancet 360:998–1000
Chiu RWK, Chan KCA, Gao Y et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A 105:20458–20463. doi:10.1073/pnas.0810641105
Chiu RWK, Sun H, Akolekar R et al (2010) Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 56:459–463. doi:10.1373/clinchem.2009.136507
Chiu RWK, Akolekar R, Zheng YWL et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342:c7401
Dhallan R, Au W-C, Mattagajasingh S et al (2004) Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 291:1114–1119. doi:10.1001/jama.291.9.1114
Ding C, Chiu RWK, Lau TK et al (2004) MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc Natl Acad Sci U S A 101:10762–10767. doi:10.1073/pnas.0403962101
Driscoll DA, Gross SJ, Professional Practice Guidelines Committee (2009) Screening for fetal aneuploidy and neural tube defects. Genet Med 11:818–821. doi:10.1097/GIM.0b013e3181bb267b
Ehrich M, Deciu C, Zwiefelhofer T et al (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 204:205.e1–11. doi:10.1016/j.ajog.2010.12.060
Fan HC, Blumenfeld YJ, Chitkara U et al (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 105:16266–16271. doi:10.1073/pnas.0808319105
Hahn S, Lapaire O, Tercanli S et al (2011) Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met? Expert Rev Mol Med 13:e16. doi:10.1017/S1462399411001852
Jackson L (2003) Fetal cells and DNA in maternal blood. Prenat Diagn 23:837–846. doi:10.1002/pd.705
Li Y, Page-Christiaens GCML, Gille JJP et al (2007) Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 27:11–17. doi:10.1002/pd.1608
Liao GJW, Lun FMF, Zheng YWL et al (2011) Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 57:92–101. doi:10.1373/clinchem.2010.154336
Lo YM, Lo ES, Watson N et al (1996) Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 88:4390–4395
Lo YM, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487. doi:10.1016/S0140-6736(97)02174-0
Lo YMD, Tsui NBY, Chiu RWK et al (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13:218–223. doi:10.1038/nm1530
Milos PM (2009) Emergence of single-molecule sequencing and potential for molecular diagnostic applications. Expert Rev Mol Diagn 9:659–666. doi:10.1586/erm.09.50
Minon J-M, Gerard C, Senterre J-M et al (2008) Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Transfusion 48:373–381. doi:10.1111/j.1537-2995.2007.01533.x
Noninvasive Prenatal Screening Work Group of the American College of Medical Genetics and Genomics, Gregg AR, Gross SJ et al (2013) ACMG statement on noninvasive prenatal screening for fetal aneuploidy. Genet Med 15:395–398. doi:10.1038/gim.2013.29
Palomaki GE, Kloza EM, Lambert-Messerlian GM et al (2011) DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 13:913–920. doi:10.1097/GIM.0b013e3182368a0e
Saito H, Sekizawa A, Morimoto T et al (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma. Lancet 356:1170. doi:10.1016/S0140-6736(00)02767-7
Sekizawa A, Purwosunu Y, Farina A et al (2007) Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood. Prenat Diagn 27:846–848. doi:10.1002/pd.1792
Stumm M, Entezami M, Trunk N et al (2012) Noninvasive prenatal detection of chromosomal aneuploidies using different next-generation sequencing strategies and algorithms. Prenat Diagn 32:569–577. doi:10.1002/pd.3862
Tounta G, Kolialexi A, Papantoniou N et al (2011) Non-invasive prenatal diagnosis using cell-free fetal nucleic acids in maternal plasma: progress overview beyond predictive and personalized diagnosis. EPMA J 2:163–171. doi:10.1007/s13167-011-0085-y
Van den Oever JME, Balkassmi S, Verweij EJ et al (2012) Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin Chem 58:699–706. doi:10.1373/clinchem.2011.174698
Van der Schoot CE, Tax GHM, Rijnders RJP et al (2003) Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17:31–44. doi:10.1053/tmrv.2003.50001
Wapner R, Thom E, Simpson JL et al (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349:1405–1413. doi:10.1056/NEJMoa025273
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 C. Alexander Valencia
About this chapter
Cite this chapter
Valencia, C.A., Pervaiz, M.A., Husami, A., Qian, Y., Zhang, K. (2013). Next-Generation–Sequencing-Based Noninvasive Prenatal Diagnosis. In: Next Generation Sequencing Technologies in Medical Genetics. SpringerBriefs in Genetics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9032-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9032-6_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9031-9
Online ISBN: 978-1-4614-9032-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)